Biogen International GmbH v. Mylan Pharmaceuticals Inc.
Pending petition
| Docket No. |
Op. Below | Argument |
Opinion |
Vote |
Author |
Term |
| 21-1567 |
Fed. Cir. |
TBD |
TBD |
TBD |
TBD |
TBD |
Issue: Whether 35 U.S.C. § 112’s requirement that a patent specification “contain a written description of the invention” is
met when the specification describes the invention, or
whether the specification must also disclose data that demonstrates the claimed invention is “effective” and emphasize the claimed invention by singling it out and describing it more than once.
